CN103566235A - Medicine for treating hepatitis B - Google Patents

Medicine for treating hepatitis B Download PDF

Info

Publication number
CN103566235A
CN103566235A CN201310533013.0A CN201310533013A CN103566235A CN 103566235 A CN103566235 A CN 103566235A CN 201310533013 A CN201310533013 A CN 201310533013A CN 103566235 A CN103566235 A CN 103566235A
Authority
CN
China
Prior art keywords
grams
medicine
hepatitis
liver
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310533013.0A
Other languages
Chinese (zh)
Inventor
孙斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310533013.0A priority Critical patent/CN103566235A/en
Publication of CN103566235A publication Critical patent/CN103566235A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a medicine for treating hepatitis B. The medicine comprises the following traditional Chinese medicine raw materials by weight: 10g of radix astragali, 10g of dangshen, 10g of semen coicis, 10g of white paeony root, 15g of salvia miltiorrhiza, 10g of cyrtomium rhizome, 30g of herba artemisiae scopariae, 15g of glossy privet fruit, 10g of largehead atractylodes rhizome, 10g of fructus toosendan, 9g of radix bupleuri, 9g of liquorice and 9g of immature bitter orange. The precision of the medicine ratio is +/-5%. Clinical use proves that the medicine for treating hepatitis B has the functions of nourishing yin and soothing the liver, strengthening the spleen and stomach, regulating qi to alleviate pain, tonifying qi and removing toxins, promoting antibody formation and protecting the liver; after being taken by patients for 1-2 courses of treatment, the medicine can not only relieve the symptoms when being taken but also thoroughly cure hepatitis B after being taken, has a quite obvious curative effect, does not have toxic or side effect and is low in price.

Description

A kind of medicine for the treatment of hepatitis B
Technical field
The present invention relates to a kind of technical field of Chinese medicines, specifically a kind of medicine for the treatment of hepatitis B.
Background technology
Hepatitis B, is called for short hepatitis B, is a kind of by caused disease after hepatitis B virus (HBV) infection body.Hepatitis B virus is a kind of Hepadna Virus, is mainly present in hepatocyte and damages hepatocyte, causes hepatocyte inflammation, necrosis, fibrosis.Hepatitis B is divided acute and chronic two kinds.Acute hepatitis B 90% can spontaneous recovery in adult, and chronic hepatitis B performance differs, and is divided into HBV chronic carrier, chronic active hepatitis B, hbv-liver cirrhosis etc.The current hepatitis B virus carrying rate of China is 7.18%, and wherein approximately 1/3rd have hepatic injury repeatedly, shows as hepatitis B or the liver cirrhosis of activeness.Along with applying of Hepatitis B virus vaccine, China's hepatitis B virus infection rate declines year by year, and 5 years old following child's HBsAg carrying rate is only 0.96%.
It is worldwide popular that hepatitis B infection is, the epidemic strength that different regions HBV infects is widely different, according to worldwide health organization, the whole world approximately 2,000,000,000 people once infected HBV, wherein 3.5 hundred million people are chronic infection person, approximately have every year 1000000 people die from HBV infect due to liver liver failure, liver cirrhosis and primary hepatocarcinoma (HCC).
The survey showed that for the prevalence of hepatitis B virus that China carried out in 2006, China 1-59 crowd hepatitis B surface antigen carrying rate is 7.18%, 5 years old following children's HBsAg carrying rate is only 0.96%, calculate accordingly, the existing Patients with Chronic HBV Infection of China approximately 9,300 ten thousand people, wherein have the activeness hepatitis B patient that symptom need to be treated to be about more than 2,000 ten thousand.
Hepatitis B is blood transmissible disease, main menses (as unsafe injection history etc.), mother-to-baby transmission and spread through sex intercourse, mucocutaneous damaged propagation also has certain proportion, as tatoo, Zha Erdong, splanchnoscopy etc., blood products is now strictly controlled, diffusibility greatly reduces, and just has generation during Blood and blood products transfusion lack of standardization.Accidental exposure in medical worker's work also can not be ignored.Along with Hepatitis B virus vaccine wideling popularize in neonate, and other mother and baby blocks the enforcement of measure, and mother-to-baby transmission is greatly controlled.HBV-DNA Positive Mothers childbirth at present approximately has 90 percent by intervening, successfully to block vertical transmission.HBV infects without respiratory tract, transmission, therefore daily study, work or life contact, as same office office appliances such as () shared computers, live a dormitory together, have a dinner in same dining room and embrace, shake hands, share lavatory etc. and can not infect HBV.Epidemiology and experimentation do not find that hepatitis B can be through hematophagus, as mosquito, bedbug bite are propagated.
At present, B-type hepatitis is that not only deficiency and excess was held concurrently but also cold and heat are held concurrently mutually mutually from tcm diagnosis and treatment, in addition hepatitis B virus is to hepatocellular destruction, consume a large amount of albumen of human body, make B-type hepatitis be difficult to radical cure, the Chinese medicine formula of the treatment B-type hepatitis of prior art can be said much, still can stably improve the medicine of body immunity and inhibition, elimination hepatitis B virus, promotion liver cell regeneration, particularly to serious symptom B-type hepatitis people, can have the few of good therapeutic effect.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art, provide a kind of and there is the merit of strengthening vital QI to eliminate pathogenic factors, the medicine of the treatment hepatitis B of the use of tonification internal organs, cold not hot not dry, the energy with cleaning hepatic diseases poison, can reach the effect for the treatment of preferably B-type hepatitis, particularly the B-type hepatitis patient of serious symptom can be pulled through and cure.Through clinical use demonstration, this medicine is relief of symptoms in use not only, and, can thorough treating hepatitis B after use, particular significant effect, has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of medicine for the treatment of hepatitis B, and it is mainly comprised of following traditional Chinese medicine raw:
Composition of the present invention and proportioning:
10 grams of the Radixs Astragali, 10 grams of Radix Codonopsis, 10 grams of meaning Semen Coicis, 10 grams of the Radix Paeoniae Albas, 15 grams of Radix Salviae Miltiorrhizaes, 10 grams of Rhizoma Osmundae, 30 grams of Artemisia anethoicles Mattf, 15 grams of Fructus Ligustri Lucidi, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Fructus Toosendan, 9 grams of Radix Bupleuri, 9 grams, Radix Glycyrrhizae, 9 grams of Fructus Aurantii Immaturuss.The degree of accuracy of above drug ratio is positive and negative 5%.
The pharmacology of this medicine is:
The Radix Astragali: nature and flavor: sweet, tepor.Gui Jing: return lung, spleen, liver, kidney channel.There is enhancing human body immunity function, protect the liver, diuresis, defying age, anti-stress, blood pressure lowering and antibacterial action more widely.
Radix Codonopsis: property is flat, sweet in the mouth, micro-acid.Return spleen, lung meridian.Invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.For deficiency of the spleen and lung, the cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency cough, interior-heat is quenched one's thirst.
Meaning Semen Coicis: sweet, be slightly cold, nontoxic.Cure mainly arthralgia chiefly caused by damp pathogen, sharp the intestines and stomach, consumer edema.Kernel is not only good nutriment, and has diuresis and antitumaous effect.Be applicable to beriberi edema, the carcinoma initial stage.Its root is for driving ascarid medicine.
The Radix Paeoniae Alba: picric acid, is slightly cold.Enter liver, spleen channel.Nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant.Control the breast abdomen pain over the hypochondriac region, dysentery stomachache, spontaneous sweating, fever due to yin deficiency, menoxenia, metrorrhagia, leukorrhagia.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature; GUIXIN, Liver Channel.For menoxenia due to blood stasis, dysmenorrhea, amenorrhea, the stagnant stomachache of the stasis of blood in puerperal; Angina pectoris, atherosclerosis; Chronic hepatitis, liver cirrhosis, abdominal masses or tumor; Chronic cardiopulmonary disease, bronchial asthma; Blood failing to tonify the heart or heart-fire are partially high, palpitation and restlessness, vexed insomnia.
Rhizoma Osmundae: bitter, puckery, be slightly cold.Return liver, stomach warp.Heat-clearing and toxic substances removing, hemostasis, parasite killing.For anemopyretic cold, encephalitis B, mumps, dysentery, discharging fresh blood stool, metrorrhagia, leukorrhagia, puerperal vim and vigour distending pain, ascarifuge and pinworm, pathopyretic ulcer.
Artemisia anethoicles Mattf: mildly bitter flavor; Micro-pungent; Cold nature.Return spleen; Stomach; Urinary bladder channel.Clearing away heat-damp and promoting diuresis; Jaundice eliminating.Cure mainly jaundice oliguria, dysuria, eczema pruritus, infectious jaundice type hepatitis.
Fructus Ligustri Lucidi: nature and flavor: sweet, hardship, flat.Gui Jing: liver; Kidney channel liver and kidney tonifying, clearind deficient heat, strong waist knee joint, improve visual and auditory acuity, black beard and hair.For the poor vision of the hepatic and renal YIN deficiency, visual deterioration, early whitening of beard and hair, soreness of waist tinnitus and fever due to yin deficiency etc.This product energy tonifying liver kidney yin, but the efficacy of a drug is gentle, must slowly get effect.
The Rhizoma Atractylodis Macrocephalae: bitter, sweet, temperature.Return spleen, stomach warp.Spleen reinforcing, stomach reinforcing, dampness, and in, antiabortive.Control deficient QI of the spleen and stomach, anorexia, asthenia weak breath, deficiency-distension, has loose bowels, phlegm retention, edema, jaundice, arthralgia chiefly caused by damp pathogen, dysuria, dizziness, spontaneous perspiration, nausea is uneasy.
Fructus Toosendan: hardship, cold; Slightly poisonous.Return liver, small intestinal, urinary bladder channel.Soothing liver-QI promoting the circulation of QI to relieve pain, except damp and hot, anthelmintic.For the breast side of body, abdominal distention, colic, abdominal pain due to worm stagnation.
Radix Bupleuri: cold nature, bitter in the mouth, pungent, return Liver Channel, gallbladder meridian, tool depressed liver-energy dispersing and function of gallbladder promoting, dredge gas resolving depression, loose effect of fire.Heating, cold and heat deficient fever cure cold.Children's's varioliform exanthema waste heat, emaciation and sallow complexion abdominal part expands, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, uterus comes off, menoxenia.
Radix Glycyrrhizae: sweet, flat.Enter spleen, stomach, lung meridian.QI invigorating invigorating middle warmer; Relieving spasm to stop pain; Nourishing the lung to arrest cough; Eliminating fire and detoxication; Coordinating the actions of various ingredients in a prescription.Main asthenia lack of appetite; Leanness yellowish complexion; Shortness of breath and palpitation; Stomachache loose stool; The anxious pain of extremity contraction; Hysteria; Cough and asthma; Laryngopharynx swelling and pain; Carbuncle skin ulcer swells and ache; Infantile carbuncle; And medicine, alimentary toxicosis.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Fructus Aurantii Immaturus: hardship; Pungent; Cold.Return spleen; Stomach; Liver; Heart channel.In stagnant, stop; Feeling of fullness distending pain; Constipation; Heavy after dysentery; Blocked-up chest; Gastroptosis; Uterine prolapse; Proctoptosis.
Its processing technology and Therapeutic Method are: take 10 grams of the Radixs Astragali, 10 grams of Radix Codonopsis, 10 grams of meaning Semen Coicis, 10 grams of the Radix Paeoniae Albas, 15 grams of Radix Salviae Miltiorrhizaes, 10 grams of Rhizoma Osmundae, 30 grams of Artemisia anethoicles Mattf, 15 grams of Fructus Ligustri Lucidi, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Fructus Toosendan, 9 grams of Radix Bupleuri, 9 grams, Radix Glycyrrhizae, 9 grams of Fructus Aurantii Immaturuss.The degree of accuracy of above drug ratio is positive and negative 5%.
The instructions of taking of this Chinese medicine:, be placed in medicine pot by above medicament mixed together, put into 1000 grams of clear water and soak after 1 hour, big fire is boiled, endures slowly with slow fire, to surplus 400 grams of water, takes potion on the one after room temperature.Every day, supper was taken after 1 hour, and serveing on 30 days is a course for the treatment of, and patient takes 1~2 course for the treatment of, can cure.
The invention has the beneficial effects as follows: the medicine of this treatment hepatitis B, through clinical use demonstration, has nourishing YIN and dispersing the stagnated liver-QI, invigorating the spleen and regulating the stomach, regulating QI to relieve pain, QI invigorating removing toxic substances, facilitates antibody to generate, liver-protective effect.Patient takes 1~2 course for the treatment of, not only can be when taking relief of symptoms, and, after taking, can thorough treating hepatitis B disease, curative effect is remarkable especially, has no side effect, cheap.
Specific embodiment
Through the clinical practice to 100 routine hepatitis Bs over 1 year, obtained good curative effect, total effective rate reaches 98%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select the projects such as medical history, the state of an illness, age and original therapy method.
2. patient originates: with general hospital patient and special chinic patient in hospital.
3. case enters group standard, according to clinical manifestation and the pathological characters of hepatitis B patient, divides, and 15 years old~70 years old age, more than course of disease January~1 year; Medicine and the therapeutic modality of various other treatment hepatitis B of stopping using before treatment.
4. administrated method: patient takes the medicine boiling every day, and once-a-day, every day, supper was taken after 1 hour, and taking continuously 30 days is a course for the treatment of, and patient takes 1~2 course for the treatment of, can cure.
5. efficacy analysis:
(1) course of disease: 1 month~2 months 48 examples, 2 months~3 months 30 examples, 3 months are 22 examples above;
(2) age group: 15 years old~30 years old 25 examples, 31 years old~40 years old 20 examples, 41 years old~50 years old 20 examples, 50 years old above 35 example;
(3) disease type and curative effect: see the following form, administration time is 1~3 course for the treatment of.
By Drug therapy hepatitis B of the present invention, received satisfied curative effect.The symptom of hepatitis B is a lot, before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain good curative effect, especially Western medicine is for oral administration, and side effect is larger, human body is caused to very major injury, and most of sufferers all be can't stand drug withdrawal voluntarily because bearing.
In taking the process of medicine of the present invention, must not take Western medicine and use injection, or the medicine of other treatment hepatitis B.
Drug administration of the present invention is without any side effects, evident in efficacy, and its cure rate reaches 95%.

Claims (1)

1. a medicine for the treatment of hepatitis B, is characterized in that: the medicine of this treatment hepatitis B is comprised of the raw material of Chinese medicine of following weight: 10 grams of the Radixs Astragali, 10 grams of Radix Codonopsis, 10 grams of meaning Semen Coicis, 10 grams of the Radix Paeoniae Albas, 15 grams of Radix Salviae Miltiorrhizaes, 10 grams of Rhizoma Osmundae, 30 grams of Artemisia anethoicles Mattf, 15 grams of Fructus Ligustri Lucidi, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Fructus Toosendan, 9 grams of Radix Bupleuri, 9 grams, Radix Glycyrrhizae, 9 grams of Fructus Aurantii Immaturuss; The degree of accuracy of above drug ratio is positive and negative 5%.
CN201310533013.0A 2013-11-04 2013-11-04 Medicine for treating hepatitis B Pending CN103566235A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310533013.0A CN103566235A (en) 2013-11-04 2013-11-04 Medicine for treating hepatitis B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310533013.0A CN103566235A (en) 2013-11-04 2013-11-04 Medicine for treating hepatitis B

Publications (1)

Publication Number Publication Date
CN103566235A true CN103566235A (en) 2014-02-12

Family

ID=50039516

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310533013.0A Pending CN103566235A (en) 2013-11-04 2013-11-04 Medicine for treating hepatitis B

Country Status (1)

Country Link
CN (1) CN103566235A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107596317A (en) * 2017-10-09 2018-01-19 刘斌 A kind of composition of medicine for suppressing hepatitis B virus duplication

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1113779A (en) * 1994-06-17 1995-12-27 殷广全 Anti- hepatitis B preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1113779A (en) * 1994-06-17 1995-12-27 殷广全 Anti- hepatitis B preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
良石等著: "《乙肝怎么看怎么办》", 31 March 2013 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107596317A (en) * 2017-10-09 2018-01-19 刘斌 A kind of composition of medicine for suppressing hepatitis B virus duplication

Similar Documents

Publication Publication Date Title
CN103007191B (en) Chinese medicinal composition for treating jaundice
CN102908603B (en) Chinese medicament for treating hyperplasia of mammary glands
CN103784887A (en) Traditional Chinese medicinal composition for treating kidney deficiency lumbago
CN103977366A (en) Medicine for treating chronic cholecystitis
CN104043022A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN104043050A (en) Traditional Chinese medicine composition for treating cholecystitis
CN104173856A (en) Traditional Chinese medicine composition for treating morbid leukorrhea
CN103816497A (en) Traditional Chinese medicinal composition for treating syndrome of liver qi stagnation
CN102949659B (en) Traditional Chinese medicine composition for treating hepatitis B
CN103394030B (en) Traditional Chinese medicine composition for treating depressed liver and deficient spleen
CN103520657B (en) Traditional Chinese medicine composition for treating obese fatty liver
CN103041301B (en) Traditional Chinese medicine composition for treating icterohepatitis
CN103705870A (en) Traditional Chinese medicine composition for treating mastitis
CN103816337A (en) Traditional Chinese medicinal composition for treating delayed menstrual cycle
CN103463397B (en) Traditional Chinese medicine composition for treating deficiency of kidney-yin
CN103566235A (en) Medicine for treating hepatitis B
CN106075265A (en) The Chinese medicine composition for the treatment of viral influenza
CN104547384A (en) Oral liquid for treating paraquat poisoning and preparation method of oral liquid
CN103800838A (en) Traditional Chinese medicine composition for treating deficiency of the kidney-yin
CN103990019A (en) Traditional Chinese medicine preparation for treating light-headedness
CN103830682A (en) Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes
CN104189661A (en) Traditional Chinese medicine for treating fibromyalgia syndrome
CN103007193B (en) Chinese medicinal composition for treating gallbladder distention
CN106266985A (en) A kind of can the pill medicine effectively treating hepatitis B and preparation method thereof
CN101015671B (en) Chinese patent drug for treating cirrhosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140212

WD01 Invention patent application deemed withdrawn after publication